Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.14B
+21.4% from 2023
Prescriptions
767K
$1,481.08 per claim
Patients
118K
58,624 prescribers
Total spending, 2024
$1.14B
$9,661.86 per patient
Medicare prescription drug plans paid $1.14B for Vraylar in 2024, for 766,576 prescriptions and refills to 117,504 patients (up 21.4% from 2023). The average cost per claim was $1,481.08.
Florida had the highest Medicare cost for Vraylar in 2024: $79.4M for 52,083 claims, followed by Ohio ($67.2M).
Robert O Morton, psychiatry in Ada, OK, had the highest Medicare cost for Vraylar in 2024: 2,852 claims costing $3.2M.
Vraylar is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Allergan Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Robert O Morton Ada, OK | Psychiatry | 2,852 | 289 | $3.2M |
| Joseph J Burgarino Milwaukee, WI | Psychiatry | 730 | 100 | $1.1M |
| Tsilya Bass West Hollywood, CA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 39,514 | 508,902 | 73,857 | $708.5M |
| 2023 | 49,250 | 633,003 | 98,181 | $935.2M |
| 2024 | 58,624 | 766,576 | 117,504 | $1.14B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Psychiatry |
| 527 |
| 65 |
| $772K |
| Jonathan A Sy Yuba City, CA | Psychiatry | 338 | 43 | $649K |
| Francis S Penland Hickory, NC | Nurse Practitioner | 399 | 55 | $622K |
| Jimmy R Mascaro Ottumwa, IA | Psychiatry | 427 | 50 | $614K |
| Megan N Chavez McAllen, TX | Physician Assistant | 415 | 86 | $601K |
| Todd J Gates West Melbourne, FL | Psychiatry | 416 | 66 | $591K |
| 1033157557 | Psychiatry | 400 | 42 | $577K |
| Patrice M Duquette Birmingham, MI | Psychiatry | 378 | 54 | $541K |
| Ming Xu Bourbonnais, IL | Psychiatry | 396 | 51 | $540K |
| Robert E Holland Brunswick, GA | Psychiatry | 347 | 57 | $533K |
| Rebecca Harding-Fauth Haverhill, MA | Nurse Practitioner | 293 | 43 | $531K |
| Keith S Bass Anna, IL | Nurse Practitioner | 342 | 36 | $522K |
| Scariya M Kumaramangalam Huntsville, AL | Psychiatry | 352 | 52 | $513K |
| Kishor Zinzuvadia Poughkeepsie, NY | Psychiatry | 332 | 41 | $511K |
| Hector R Corzo Pinellas Park, FL | Psychiatry | 319 | 39 | $465K |
| Jonathan C Lockhart Longview, TX | Psychiatry & Neurology | 289 | 35 | $462K |
| Larry M Neuman New York, NY | Internal Medicine | 309 | 66 | $457K |
| Nicole Delagardelle Waterloo, IA | Nurse Practitioner | 312 | 48 | $455K |
| Sanjeev Rao Bridgeport, CT | Internal Medicine | 272 | 40 | $440K |
| Kelli N Bridgman Deland, FL | Nurse Practitioner | 289 | 64 | $439K |
| John W Head Jr. Detroit, MI | Psychiatry | 314 | 73 | $437K |
| Paul Gould Lakeville, MA | Nurse Practitioner | 265 | 39 | $433K |
| Lee A Keller Salem, KY | Nurse Practitioner | 288 | 41 | $430K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Allergan Inc. ABBV | 766,962 | $1.14B |